AG

Artal Group Portfolio holdings

AUM $930M
This Quarter Return
+22.25%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$4.52B
AUM Growth
+$4.52B
Cap. Flow
-$931K
Cap. Flow %
-0.02%
Top 10 Hldgs %
91.49%
Holding
100
New
10
Increased
15
Reduced
23
Closed
3

Top Buys

1
GS icon
Goldman Sachs
GS
$22.2M
2
NBIX icon
Neurocrine Biosciences
NBIX
$10.4M
3
MDCO
Medicines Co
MDCO
$9.5M
4
INCY icon
Incyte
INCY
$9.44M
5
NKTR icon
Nektar Therapeutics
NKTR
$7.82M

Top Sells

1
BABA icon
Alibaba
BABA
$27M
2
ATH
Athene Holding Ltd. Class A Common Shares
ATH
$12.4M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
$6.81M
4
SAGE
Sage Therapeutics
SAGE
$6.77M
5
ZTO icon
ZTO Express
ZTO
$6.28M

Sector Composition

1 Consumer Staples 44.29%
2 Healthcare 31.71%
3 Consumer Discretionary 21.77%
4 Financials 0.83%
5 Industrials 0.15%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
LRMR icon
51
Larimar Therapeutics
LRMR
$337M
$3.51M 0.06%
83,333
– –
JNCE
52
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$3.51M 0.06%
250,000
-50,000
-17% -$702K
ALDR
53
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$3.44M 0.06%
300,000
– –
RGNX icon
54
Regenxbio
RGNX
$498M
$3.16M 0.06%
160,000
– –
RARE icon
55
Ultragenyx Pharmaceutical
RARE
$3.04B
$3.11M 0.05%
50,000
+20,000
+67% +$1.24M
FCX icon
56
Freeport-McMoran
FCX
$66.3B
$3M 0.05%
+250,000
New +$3M
ONCE
57
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$2.99M 0.05%
50,000
– –
CALA
58
DELISTED
Calithera Biosciences, Inc
CALA
$2.97M 0.05%
+10,000
New +$2.97M
GBT
59
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2.74M 0.05%
100,000
-75,000
-43% -$2.05M
CMRX
60
DELISTED
Chimerix, Inc.
CMRX
$2.73M 0.05%
500,000
– –
PRQR icon
61
ProQR Therapeutics
PRQR
$256M
$2.6M 0.05%
500,000
+100,000
+25% +$520K
CLLS
62
Cellectis
CLLS
$260M
$2.58M 0.05%
100,000
-50,000
-33% -$1.29M
IMUX icon
63
Immunic
IMUX
$79.4M
$2.54M 0.04%
21,875
– –
NVLN
64
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$2.37M 0.04%
256,400
– –
CLVS
65
DELISTED
Clovis Oncology, Inc.
CLVS
$2.34M 0.04%
+25,000
New +$2.34M
STML
66
DELISTED
Stemline Therapeutics, Inc.
STML
$2.3M 0.04%
250,000
+150,000
+150% +$1.38M
CBIO
67
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
$2.26M 0.04%
+2,025
New +$2.26M
NERV icon
68
Minerva Neurosciences
NERV
$16.8M
$2.22M 0.04%
31,413
– –
AIMT
69
DELISTED
Aimmune Therapeutics, Inc.
AIMT
$2.06M 0.04%
100,000
-81,600
-45% -$1.68M
IBRX icon
70
ImmunityBio
IBRX
$2.24B
$1.71M 0.03%
225,000
– –
CLDX icon
71
Celldex Therapeutics
CLDX
$1.57B
$1.67M 0.03%
45,000
– –
CRBP icon
72
Corbus Pharmaceuticals
CRBP
$119M
$1.58M 0.03%
+8,333
New +$1.58M
ADAP
73
Adaptimmune Therapeutics
ADAP
$13.9M
$1.35M 0.02%
300,000
– –
KDNY
74
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1.14M 0.02%
20,000
– –
VSTM icon
75
Verastem
VSTM
$585M
$1.09M 0.02%
+41,667
New +$1.09M
1 2
3
4